ALGN vs GMAB
Align Technology vs Genmab A/S — AI-powered side-by-side comparison
ALGN
Align Technology
73
Buy
VS
| Metric | ALGN | GMAB |
|---|
| AI Score |
73
|
60
|
| Price |
$172.86
|
$30.82
|
| P/E Ratio |
30.03×
|
24.04×
|
| ROE |
10.1%
|
16.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
66.5%
|
39.9%
|
| Debt / Equity |
0.03×
|
0.89×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
55.1
|
72.5
|
| Beta |
1.653
|
0.685
|
| Expected Upside |
+7.7%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALGN versus GMAB.
ALGN leads by 13 points.
ALGN scores 73/100 (Buy) versus GMAB at 60/100 (Buy).
ALGN Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
GMAB Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- EPS declining -25.3% YoY despite any revenue growth — Growth
- RSI at 73 is in overbought territory — Technical